CBD Life Sciences Inc.
Raising nowOperatingBiotech · Scottsdale, AZ
CBD Life Sciences develops and makes its own CBD products, such as hemp oil drops, pet treats and topicals, and also sells white-label and third-party products. Sales run through its Scottsdale, Arizona retail store, The CBD Vault, its website, and online marketplaces such as Walmart Marketplace and Groupon.
This company has an open fundraising round.
Financials
FY2018–FY2025 (no data for FY2020, FY2022, FY2024) · from SEC filings · hover any figure for its sourceFigures as reported by the issuer in the filing shown on hover. Each year’s pill shows the assurance level of its filed statements — audited, reviewed (CPA review, less than an audit), or unaudited, as the filing’s own report or certification states it. A dashed pill marked * is inferred instead: the SEC minimum for an offering that size, which the issuer may have exceeded. No pill means we couldn’t tell. Headcount is the filing’s point-in-time count, not a year-end average. Manually corrected figures are marked “Corrected”.
Valuation over rounds
Pre-money — the valuation set before each round’s money came inDotted grey bars are our estimate for rounds that didn't state one: the round's share price × the shares outstanding in its filings. Same measure as blue, but rougher.
Share price over rounds
“Today's shares” restates every price in the share terms current now, so a price before a split or an LLC→corporation conversion is divided by that event's ratio (each event is cited on the round page). Disclosed sales come from the issuer's own filings (prior-offering lines, audited-statement notes) and are amount ÷ securities sold. A down round is a firm point more than 25 % below the previous firm point of the same share class on a comparable basis; the comparison ignores unverified and year-only lines.
Cap table
Share counts as of May 15, 2026| Class | Outstanding | Votes / share | Share of total | Liquidation | Last price |
|---|---|---|---|---|---|
| Series A Non-Convertible Preferred Stockpreferred | 66,081,530 | — | 1.15% | 1× non-participating | — |
| Common Stock | 5,696,998,727 | — | 98.8% | — | $0.0001Jun 2026 |
| Total | 5,763,080,257 | 100% |
Shares outstanding over timein today's share terms
Changes in named holdersshares in today's terms · % of all shares at the time
- Brianna Nelson7K (12.4%) Apr 2020 → 157K (71.4%) Sep 2020 → 451M (682.0%) Aug 2024 → 451M May 2026
- Lisa Nelson147K (273.6%) Feb 2020 → 17K (31.1%) Apr 2020 → 183K (83.2%) Sep 2020 → 220K Aug 2022 → 66M (100.0%) May 2024
- Matthew McGee0 (0%) Jun 2024 → 450M (681.0%) Aug 2024
- George Rutherford37K (68.9%) Apr 2020 → 37K (16.8%) Jun 2021
Principal holders% as the filing states it, May 15, 2026
- Lisa Nelson66,081,530 Series A Non-Convertible Preferred Stock100.0%of Series A Non-Convertible Preferred
- Brianna Nelson450,657,342 Common Stock7.91%of company
- Matthew McGee450,000,000 Common Stock7.9%of company
- Jennifer Simmons200,500,000 Common Stock3.52%of company
- Lisa Nelson200,476,989 Common Stock3.52%of company
- Brian John Nisky200,000,000 Common Stock3.51%of company
- Everyone else (not named in filings)73.6%
Sold to the crowd
- Reg A+ · May 2019261,281 shares at $30.00 in today's terms · sold as 78,384,200 shares at $0.10; since then a 1-for-300 reverse split (Apr 2024)$7.8M
- Reg A+ · Aug 20221,822,111 shares at $0.09 in today's terms · sold as 546,633,333 Common Stock at $0.0003; since then a 1-for-300 reverse split (Apr 2024)$164K
From the company's SEC filings: share counts per class, each class's voting and conversion terms, and the holders of 20% or more that Form C requires (officers and 10%+ holders on Form 1-A). Filings name only large holders, so most owners — including crowd investors — are not listed, and a holder's percentage may be of its own class rather than of the whole company. Prices and crowd share counts are in today's share terms — adjusted for splits and conversions since they were sold. Hover a figure for its filing.
Fundraising history
Team
2 peopleNames and titles as disclosed on SEC Form 1-A. Bios and photos come from the platform campaign page and may be out of date.
SEC filings
View all 46 filings on EDGAR- Form QUALIFJun 8, 20269999999994-26-000116EDGAR
- Form 1-AMay 15, 20260001683168-26-004020EDGAR
- Form 253G2May 19, 20250001683168-25-003804EDGAR
- Form QUALIFMar 19, 20259999999994-25-000047EDGAR
- Form 1-A POSMar 17, 20250001683168-25-001657EDGAR
- Form 1-A POSMar 6, 20250001683168-25-001387EDGAR
- Form 1-UJan 22, 20250001683168-25-000468EDGAR
- Form 253G2Sep 19, 20240001683168-24-006519EDGAR
About this data. Figures are compiled from public sources — SEC EDGAR filings (Form C, C-AR, 1-A, 1-K) and funding-platform pages — and may be delayed, incomplete, or restated by the issuer. Financial statements are as reported by the issuer; each year is labeled with its assurance level (audited / reviewed / unaudited). A valuation cap is the conversion ceiling of a SAFE or convertible note, not an agreed company valuation; post-money figures are computed as pre-money plus amount raised and are not a traded price. Crowdonomics is not a broker-dealer, funding portal, or investment adviser; nothing here is investment advice or an offer to sell securities. Verify all figures against the linked EDGAR filings.